blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3837016

EP3837016 - CHIMERIC QUIESCIN SULFHYDRYL OXIDASE (QSOX1) ANTIBODIES AND USES OF SAME [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  02.06.2023
Database last updated on 24.08.2024
FormerExamination is in progress
Status updated on  23.09.2022
FormerRequest for examination was made
Status updated on  21.05.2021
FormerThe international publication has been made
Status updated on  24.02.2020
Formerunknown
Status updated on  10.09.2019
Most recent event   Tooltip02.06.2023Application deemed to be withdrawnpublished on 05.07.2023  [2023/27]
Applicant(s)For all designated states
Yeda Research and Development Co. Ltd.
at the Weizmann Institute of Science
P.O. Box 95
7610002 Rehovot / IL
[2021/25]
Inventor(s)01 / FASS, Deborah
7 Mohliver Street
7630422 Rehovot / IL
02 / FLEISHMAN, Sarel
c/o Yeda Research And Development Co. Ltd.,
at the Weizmann Institute of Science
P.O. Box 95
7610002 Rehovot / IL
03 / WARSZAWSKI, Shira
c/o Yeda Research And Development Co. Ltd.
at the Weizmann Institute of Science
P.O. Box 95
7610002 Rehovot / IL
04 / GROSSMAN, Iris
c/o Yeda Research And Development Co. Ltd.
at the Weizmann Institute of Science
P.O. Box 95
7610002 Rehovot / IL
05 / KHMELNITSKY, Lev
c/o Yeda Research And Development Co. Ltd.
at the Weizmann Institute of Science
P.O. Box 95
7610002 Rehovot / IL
 [2021/25]
Representative(s)Dennemeyer & Associates S.A.
Postfach 70 04 25
81304 München / DE
[2021/25]
Application number, filing date19761972.914.08.2019
[2021/25]
WO2019IL50914
Priority number, dateIL2018026115614.08.2018         Original published format: IL 26115618
[2021/25]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2020035863
Date:20.02.2020
Language:EN
[2020/08]
Type: A1 Application with search report 
No.:EP3837016
Date:23.06.2021
Language:EN
The application published by WIPO in one of the EPO official languages on 20.02.2020 takes the place of the publication of the European patent application.
[2021/25]
Search report(s)International search report - published on:EP20.02.2020
ClassificationIPC:A61P35/00, C07K16/40, C07K16/46
[2021/25]
CPC:
C07K16/40 (EP,US); A61P35/00 (EP); C07K16/462 (EP);
C07K2317/24 (EP,US); C07K2317/56 (EP); C07K2317/565 (US);
C07K2317/76 (EP); C07K2317/92 (EP); C07K2317/94 (EP) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/25]
TitleGerman:CHIMÄRE QUIESCIN-SULFHYDRYL-OXIDASE(QSOX1)-ANTIKÖRPER UND VERWENDUNGEN DAVON[2021/25]
English:CHIMERIC QUIESCIN SULFHYDRYL OXIDASE (QSOX1) ANTIBODIES AND USES OF SAME[2021/25]
French:ANTICORPS CHIMÉRIQUES DE QUIESCINE SULFHYDRYL OXYDASE (QSOX1) ET LEURS UTILISATIONS[2021/25]
Entry into regional phase01.03.2021National basic fee paid 
01.03.2021Designation fee(s) paid 
01.03.2021Examination fee paid 
Examination procedure01.03.2021Amendment by applicant (claims and/or description)
01.03.2021Examination requested  [2021/25]
01.03.2021Date on which the examining division has become responsible
26.09.2022Despatch of a communication from the examining division (Time limit: M04)
07.02.2023Application deemed to be withdrawn, date of legal effect  [2023/27]
28.02.2023Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2023/27]
Fees paidRenewal fee
13.08.2021Renewal fee patent year 03
Penalty fee
Additional fee for renewal fee
31.08.202204   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XY]WO2013132495  (YEDA RES & DEV [IL]) [X] 1-5,8-11,17-37 * page 87, paragraph last; claim all; sequences 27, 28 * [Y] 6,7,12-16;
 [A]WO2017072757  (YEDA RES & DEV [IL]) [A] 1-37 * claim all *;
 [A]  - IRIS GROSSMAN ET AL, "Overcoming a species-specificity barrier in development of an inhibitory antibody targeting a modulator of tumor stroma", PROTEIN ENGINEERING, DESIGN AND SELECTION, GB, (20160126), vol. 29, no. 4, doi:10.1093/protein/gzv067, ISSN 1741-0126, pages 135 - 147, XP055334671 [A] 1-37 * example allall *

DOI:   http://dx.doi.org/10.1093/protein/gzv067
 [Y]  - KOENIG ET AL, "Mutational landscape of antibody variable domains reveals a switch modulating the interdomain conformational dynamics and antigen binding", PNAS, (20170101), vol. 114, no. 4, doi:10.1073/pnas.1613231114, pages E486 - E495, XP055578865 [Y] 6,7,12-16 * abstract *

DOI:   http://dx.doi.org/10.1073/pnas.1613231114
 [A]  - CHARLES M. FORSYTH ET AL, "Deep mutational scanning of an antibody against epidermal growth factor receptor using mammalian cell display and massively parallel pyrosequencing", MABS, US, (20130727), vol. 5, no. 4, doi:10.4161/mabs.24979, ISSN 1942-0862, pages 523 - 532, XP055645859 [A] 1-37 * figure all; example all *

DOI:   http://dx.doi.org/10.4161/mabs.24979
by applicantUS3791932
 US3839153
 US3850752
 US3850578
 US3853987
 US3867517
 US3879262
 US3901654
 US3935074
 US3984533
 US3996345
 US4034074
 US4036945
 US4098876
 US4275149
 US4331647
 US4666828
 US4683202
 US4801531
 US4816567
 US4879219
 US4946778
 US5011771
 US5192659
 US5272057
 US5281521
 US5464764
 US5487992
 US5545807
 US5545806
 US5569825
 US5625126
 US5633425
 US5661016
 US6037137
 US6350466
 WO2013132495
 US2017032079
 WO2017017673
    - ILANI, T. et al., Science, (20130000), vol. 341, pages 74 - 76
    - GROSSMAN I. et al., J. Mol. Biol., (20130000), vol. 425, pages 4366 - 4378
    - "NCBI", Database accession no. NP_002817
    - BOWIE et al., Science, (19900000), vol. 247, page 1306 1310
    - VERHOEYEN et al., Science, (19880000), vol. 239, pages 1534 - 1536
    - PORTER, R. R., Biochem. J., (19590000), vol. 73, pages 119 - 126
    - INBAR et al., Proc. Nat'l Acad. Sci. USA, vol. 69, pages 2659 - 62
    - WHITLOWFILPULA, Methods, (19910000), vol. 2, pages 106 - 105
    - PACK et al., Bio/Technology, (19930000), vol. 11, pages 1271 - 77
    - JONES et al., Nature, (19860000), vol. 321, pages 522 - 525
    - RIECHMANN et al., Nature, (19880000), vol. 332, pages 323 - 327
    - PRESTA, Curr. Op. Struct. Biol., (19920000), vol. 2, pages 593 - 596
    - HOOGENBOOMWINTER, J. Mol. Biol., (19910000), vol. 222, page 581
    - COLE et al., Monoclonal Antibodies and Cancer Therapy, Alan R. Liss, (19850000), page 77
    - BOERNER et al., J. Immunol., (19910000), vol. 147, no. 1, pages 86 - 95
    - MARKS et al., Bio/Technology, (19920000), vol. 10, pages 779 - 783
    - LONBERG et al., Nature, (19940000), vol. 368, pages 812 - 859
    - FISHWILD et al., Nature Biotechnology, (19960000), vol. 14, pages 826 - 51
    - LONBERGHUSZAR, Intern. Rev. Immunol., (19950000), vol. 13, pages 65 - 93
    - ISHIKAWA E. et al., J Immunoassay, (19830000), vol. 4, pages 209 - 327
    - TILLER et al., Journal of Immunological Methods, (20080000), vol. 329, pages 112 - 124
    - KAY M. et al., Biochemistry, (19950000), vol. 34, page 293
    - GILBOA, Biotechniques, (19860000), vol. 4, no. 6, pages 504 - 512
    - GRAHAM et al., J. Gen Virol., (19770000), vol. 36, page 59
    - Mather, Biol. Reprod., (19800000), vol. 23, pages 243 - 251
    - MATHER et al., Annals N.Y. Acad. Sci., (19820000), vol. 383, pages 44 - 68
    - HIROMITSU HAYASHITAKAO SAKAIL, Amer Journal Physiol - GI, (20110000), vol. 300, no. 5, pages G729 - G738
    - ANNA FANTOZZIGERHARD CHRISTOFORI, Breast Cancer Research, (20060000), vol. 8, page 212
    - FINGL et al., The Pharmacological Basis of Therapeutics, (19750000), page l
    - HIROMURA et al., J. Biol. Chem., (20040000), vol. 279, pages 53407 - 53418
    - KOZIKOWSKI et al., J. Am. Chem. Soc., (20030000), vol. 125, pages 1144 - 1145
    - KAU et al., Cancer Cell, (20030000), vol. 4, pages 463 - 476
    - WISDOM GB., Methods Mol Biol., (19940000), vol. 32, pages 433 - 40
    - STUBBS et al., Biochemistry, (19960000), vol. 35, page 937
    - KHATKHATAY MI.DESAI M., J Immunoassay, (19990000), vol. 20, pages 151 - 83
    - OELLERICH M., J Clin Chem Clin Biochem., (19800000), vol. 18, pages 197 - 208
    - SCHUURS AH.VAN WEEMEN BK., J Immunoassay, (19800000), vol. 1, pages 229 - 49
    - DENKBERG, G. et al., Eur. J. Immunol., (20000000), vol. 30, pages 3522 - 3532
    - CLOUTIER SM. et al., Molecular Immunology, (20000000), vol. 37, pages 1067 - 1077
    - DUBEL S. et al., J Immunol Methods, (19950000), vol. 178, page 201
    - HUSTON JS. et al., Methods in Enzymology, (19910000), vol. 203, page 46
    - KIPRIYANOV SM. et al., Hum Antibodies Hybridomas, (19950000), vol. 6, page 93
    - KIPRIYANOV SM. et al., Protein Engineering, (19960000), vol. 9, page 203
    - PEARCE LA. et al., Biochem Molec Biol Intl, (19970000), vol. 42, pages 1179 - 1188
    - TILLER et al., J. Immunol. Methods, (20080000), vol. 329, pages 112 - 124
    - ROST, B., Protein Eng, (19990000), vol. 12, no. 2, pages 85 - 94
    - EDGAR, R.C., Nucleic Acids Res, (20040000), vol. 32, no. 5, pages 1792 - 1797
    - SCHAFFER, A.A. et al., Nucl. Acids Res., (20010000), vol. 29, no. 14, pages 2994 - 3005
    - EDDY, S.R., Nat Biotechnol, (20040000), vol. 22, no. 8, pages 1035 - 6
    - GOLDENZWEIG, A. et al., Mol Cell., (20160000), vol. 63, no. 2, pages 337 - 346
    - Current Protocols in Molecular Biology, Appleton & Lange, (19940000), vol. I-III
    - WATSON et al., Genome Analysis: A Laboratory Manual Series, Cold Spring Harbor Laboratory Press, (19980000), vol. 1-4
    - PCR Protocols: A Guide To Methods And Applications, Academic Press, (19900000), vol. 1-317
    - UNGER, T.JACOBOVITCH, Y.DANTES, A.BERNHEIM, R.PELEG, Y., "Applications of the Restriction Free (RF) cloning procedure for molecular manipulations and protein expression", J. Struct. Biol., (20100000), vol. 172, pages 34 - 44, XP027249555
    - ISRAEL, B. A.JIANG, L.GANNON, S. A.THORPE, C., "Disulfide bond generation in mammalian blood serum: detection and purification of quiescin-sulfhydryl oxidase", Free Radic. Biol. Med., (20140000), vol. 69, pages 129 - 135
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.